Physician profile
Kevin Howe
NPI 1225124076
$1,862.36
in general payments reported to CMS, 2019-2025
10 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $17.27 · 2021: $255 · 2022: $65.33 · 2023: $638 · 2024: $462 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268 · Travel and Lodging: $95.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,268.45 |
| Travel and Lodging | $95.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $873.88 | 2019-2024 | Velys, Attune, Emphasys |
| Orthalign INC | $485.01 | 2023-2025 | Orthalign Plus |
| Medical Device Business Services, INC. | $211.07 | 2023-2024 | Velys, Attune |
| Evolution Surgical, INC | $86.18 | 2023 | |
| Derma Sciences, INC. | $61.14 | 2019 | |
| Avanos Medical | $54.35 | 2021-2024 | On-Q* Pump and Accessories |
| Smith+Nephew, INC. | $28.67 | 2025 | Legion |
| Vertex Pharmaceuticals Incorporated | $24.36 | 2025 | |
| Ethicon US, LLC | $20.43 | 2022 | |
| Zimmer Biomet Holdings, INC. | $17.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Howe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.